News
Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...
New Scientist on MSN5d
You don't need to take drugs like Ozempic consistently to lose weightPeople who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
Binge eating disorder is strongly associated with weight gain and obesity, though not all individuals with obesity have BED.
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...
News-Medical.Net on MSN4d
Retrospective analyses indicate Ozempic’s protective effects against stroke fatalityThree studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
Irish Examiner on MSN4d
‘My mom never knew she had dementia — it would have devastated her’Neuroscientist Sabina Brennan encourages caregivers to live in the moment and notice the happy experiences they share with ...
Explore how semaglutide and tirzepatide may protect against dementia and stroke—keep reading for clinical implications and evidence.
Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback